"Radioligand Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders).
| Descriptor ID |
D011869
|
| MeSH Number(s) |
E01.370.225.985 E01.370.374.650 E01.370.384.720 E05.200.985
|
| Concept/Terms |
Radioligand Assay- Radioligand Assay
- Assay, Radioligand
- Assays, Radioligand
- Radioligand Assays
- Radioreceptor Assay
- Assay, Radioreceptor
- Assays, Radioreceptor
- Radioreceptor Assays
- Protein-Binding Radioassay
- Protein Binding Radioassay
- Protein-Binding Radioassays
- Radioassay, Protein-Binding
- Radioassays, Protein-Binding
|
Below are MeSH descriptors whose meaning is more general than "Radioligand Assay".
Below are MeSH descriptors whose meaning is more specific than "Radioligand Assay".
This graph shows the total number of publications written about "Radioligand Assay" by people in this website by year, and whether "Radioligand Assay" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 14 | 14 |
| 1996 | 0 | 10 | 10 |
| 1997 | 1 | 4 | 5 |
| 1998 | 0 | 10 | 10 |
| 1999 | 0 | 9 | 9 |
| 2000 | 0 | 7 | 7 |
| 2001 | 2 | 10 | 12 |
| 2002 | 0 | 20 | 20 |
| 2003 | 2 | 11 | 13 |
| 2004 | 0 | 13 | 13 |
| 2005 | 0 | 13 | 13 |
| 2006 | 0 | 10 | 10 |
| 2007 | 1 | 4 | 5 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 7 | 7 |
| 2010 | 0 | 5 | 5 |
| 2011 | 2 | 11 | 13 |
| 2012 | 1 | 5 | 6 |
| 2013 | 1 | 3 | 4 |
| 2014 | 0 | 5 | 5 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 4 | 4 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 3 | 3 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 1 | 1 |
Below are the most recent publications written about "Radioligand Assay" by people in Profiles.
-
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB1 receptors. Drug Test Anal. 2021 Jul; 13(7):1383-1401.
-
Cannabinoid receptor Type 1 densities reflect social organization in Microtus. J Comp Neurol. 2021 04 01; 529(5):1004-1017.
-
The 2-/16α-Hydroxylated Estrogen Ratio-Breast Cancer Risk Hypothesis: Insufficient Evidence for its Support. J Steroid Biochem Mol Biol. 2020 07; 201:105685.
-
Docking Finds GPCR Ligands in Dark Chemical Matter. J Med Chem. 2020 01 23; 63(2):613-620.
-
Detecting neuroinflammation in the brain following chronic alcohol exposure in rats: A comparison between in vivo and in vitro TSPO radioligand binding. Eur J Neurosci. 2019 07; 50(1):1831-1842.
-
Rubiscolins are naturally occurring G protein-biased delta opioid receptor peptides. Eur Neuropsychopharmacol. 2019 03; 29(3):450-456.
-
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA. Drug Test Anal. 2019 Feb; 11(2):279-291.
-
Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor. Nat Commun. 2018 02 14; 9(1):674.
-
Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology. 2017 Jul; 42(8):1630-1639.
-
Divergent Mechanisms Leading to Signaling Dysfunction in Embryonic Muscle by Bisphenol A and Tetrabromobisphenol A. Mol Pharmacol. 2017 04; 91(4):428-436.